Danish Pharmacovigilance Update, April 2016
10 May 2016
News from the EU
- The European Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of the risk of amputations in connection with canagliflozin treatment
- EU's list of recommendations on safety signals
News from the Danish Medicines Agency
- Reports of cardiac arrest after treatment with methylphenidate
- Influenza vaccines and reports of suspected adverse reactions
Short news
- Most recent Direct Healthcare Professional Communications (DHPCs)
- Information material for healthcare professionals and patients about biological medicines and biosimilars